M&A

Here's Why Bristol Myers Offered MyoKardia $13.1 Billion
Motley Fool
Wed, 10/7/20 - 10:52 am
M&A
MyoKardia
Bristol-Myers Squibb
Bristol Myers to buy MyoKardia in $13B bet on targeted drugs for the heart
BioPharma Dive
Mon, 10/5/20 - 11:52 am
Bristol-Myers Squibb
M&A
MyoKardia
genetic heart disease
Why Ilumina's Stock Fell 13.5% in September
Motley Fool
Sun, 10/4/20 - 10:58 pm
Illumina
Grail
M&A
gene sequencing
Will Big Pharma Acquire Novavax?
Motley Fool
Sun, 10/4/20 - 12:14 am
Novavax
vaccines
M&A
Big Pharma
pandemic
COVID-19
CPhl event to draw attention to M&A activity in gene and cell sector
Biopharma Reporter
Thu, 10/1/20 - 10:07 am
M&A
gene therapy
cell therapy
CPhI
Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Endpoints
Thu, 10/1/20 - 10:01 am
Lysosomal Therapeutics
Allergan
R&D
M&A
Henri Termeer
Bial
Smith & Nephew to Buy Integra Unit for $240M Cash
Medical Devices and Diagnostics Industry
Wed, 09/30/20 - 10:56 pm
Smith & Nephew
M&A
Orthopedics
Integra LifeSciences
devices
Orgenesis inks Koligo buyout to gain COVID-19 cell therapy
Fierce Biotech
Tue, 09/29/20 - 11:47 am
Orgenesis
M&A
Koligo Therapeutics
autologous cell therapy
COVID-19
Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst
Fierce Pharma
Thu, 09/24/20 - 11:26 pm
Gilead Sciences
Immunomedics
M&A
Trodelvy
ESMO
breast cancer
Is Illumina Making an $8 Billion Blunder?
Motley Fool
Tue, 09/22/20 - 10:54 am
Illumina
Grail
M&A
diagnostics
investors
Vifor Pharma Group announces successful sale of OM Pharma
Pharmaceutical Business Review
Mon, 09/21/20 - 10:29 am
Vifor Pharma
OM Pharma
Optimus Holding
M&A
Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field
Fierce Biotech
Mon, 09/21/20 - 10:28 am
Roche
M&A
Inflazome
inflammatory disease
Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Motley Fool
Wed, 09/16/20 - 07:45 pm
M&A
diagnostics
cancer diagnostics
cancer
oncology
Illumina
Grail
The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19
Endpoints
Tue, 09/15/20 - 11:01 am
Nestle
M&A
Aimmune
Palforzia
COVID-19
pandemic
peanut allergy
Gilead to buy cancer drugmaker Immunomedics for $21B
BioPharma Dive
Sun, 09/13/20 - 10:26 pm
Gilead Sciences
M&A
cancer
Immunomedics
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
Pharmafile
Tue, 09/8/20 - 10:33 pm
Takeda
Cheplapharm
M&A
Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
Endpoints
Tue, 09/8/20 - 10:55 am
Mylan
Europe
generics
Aspen Pharmacare
M&A
thrombosis
Pfizer
J&J, free from rival bidders, made Momenta wait on $6.5B deal
Fierce Biotech
Thu, 09/3/20 - 10:07 am
JNJ
Momenta Pharmaceuticals
M&A
Bayer Agrees To Buy Personalized Vitamin Company Care/of At $225 Million Valuation
Forbes
Tue, 09/1/20 - 10:50 pm
Bayer
M&A
Care/of
consumer health
Nestle pays $2 billion to secure Aimmune’s allergy treatment
CNBC
Mon, 08/31/20 - 10:54 am
Aimmune
Nestle
M&A
peanut allergy
Palforzia

Pages